首页> PloS one> A multifactorial model of T cell expansion and durable clinical benefit in response to a PD-L1 inhibitor.

A multifactorial model of T cell expansion and durable clinical benefit in response to a PD-L1 inhibitor.

导出 OA

翻译打印收藏纠错

第一作者： Mark D M,Leiserson

第一单位： Microsoft Research New England, Cambridge, MA, United States of America.;University of Maryland, College Park, Department of Computer Science, College Park, MD, United States of America.

作者： Mark D M,Leiserson ^[1] ; Vasilis,Syrgkanis ^[2] ; Amy,Gilson ^[2] ; Miroslav,Dudik ^[3] ; Sharon,Gillett ^[2] ; Jennifer,Chayes ^[4] ; Christian,Borgs ^[2] ; Dean F,Bajorin ^[5] ; Jonathan E,Rosenberg ^[6] ; Samuel,Funt ^[5] ; Alexandra,Snyder ^[7] ; Lester,Mackey ^[2]

作者单位： Microsoft Research New England, Cambridge, MA, United States of America.;University of Maryland, College Park, Department of Computer Science, College Park, MD, United States of America. ^[1] Microsoft Research New England, Cambridge, MA, United States of America. ^[2] Microsoft Research New York, New York, NY, United States of America. ^[3] Microsoft Research New England, Cambridge, MA, United States of America.;Microsoft Research New York, New York, NY, United States of America. ^[4] Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America.;Department of Medicine, Weill Cornell Medical College, New York, NY, United States of America. ^[5] Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America. ^[6] Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America.;Adaptive Biotechnologies, Seattle, WA, United States of America. ^[7]